OBJECTIVES: To discuss the role of clinical trials in the changing landscape of cancer care resulting in individualized cancer treatment plans including a discussion of several innovative randomized studies designed to evaluate multiple targeted therapies in molecularly defined subsets of individuals. DATA SOURCES: Medical and nursing literature, research articles, and clinicaltrials.gov. CONCLUSION: Recent advancements in cancer biomarkers and biomedical technology have begun to transform fundamentals of cancer therapeutics and clinical trials through innovative adaptive trial designs. The goal of these studies is to learn not only if a drug is safe and effective but also how it is best delivered and who will derive the most benefit. IMPLICATIONS FOR NURSING PRACTICE: Implementation of clinical trials in the cancer biomarker era requires knowledge, skills, and expertise related to the use of biomarkers and molecularly defined processes underlying a malignancy, as well as an understanding of associated ethical, legal, and social issues to provide competent, safe, and effective health care and patient communication. Published by Elsevier Inc.
OBJECTIVES: To discuss the role of clinical trials in the changing landscape of cancer care resulting in individualized cancer treatment plans including a discussion of several innovative randomized studies designed to evaluate multiple targeted therapies in molecularly defined subsets of individuals. DATA SOURCES: Medical and nursing literature, research articles, and clinicaltrials.gov. CONCLUSION: Recent advancements in cancer biomarkers and biomedical technology have begun to transform fundamentals of cancer therapeutics and clinical trials through innovative adaptive trial designs. The goal of these studies is to learn not only if a drug is safe and effective but also how it is best delivered and who will derive the most benefit. IMPLICATIONS FOR NURSING PRACTICE: Implementation of clinical trials in the cancer biomarker era requires knowledge, skills, and expertise related to the use of biomarkers and molecularly defined processes underlying a malignancy, as well as an understanding of associated ethical, legal, and social issues to provide competent, safe, and effective health care and patient communication. Published by Elsevier Inc.
Authors: Nadia Godin-Heymann; Ianthe Bryant; Miguel N Rivera; Lindsey Ulkus; Daphne W Bell; David J Riese; Jeffrey Settleman; Daniel A Haber Journal: Cancer Res Date: 2007-08-01 Impact factor: 12.701
Authors: Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron Journal: N Engl J Med Date: 2009-08-19 Impact factor: 91.245
Authors: Edward S Kim; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Yi-Long Wu; Long-Yun Li; Claire L Watkins; Mark V Sellers; Elizabeth S Lowe; Yan Sun; Mei-Lin Liao; Kell Osterlind; Martin Reck; Alison A Armour; Frances A Shepherd; Scott M Lippman; Jean-Yves Douillard Journal: Lancet Date: 2008-11-22 Impact factor: 79.321
Authors: Jean-Yves Douillard; Frances A Shepherd; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Mei-Lin Liao; Helge Bischoff; Martin Reck; Mark V Sellers; Claire L Watkins; Georgina Speake; Alison A Armour; Edward S Kim Journal: J Clin Oncol Date: 2009-12-28 Impact factor: 44.544
Authors: Abanish Singh; Michael A Babyak; Mario Sims; Solomon K Musani; Beverly H Brummett; Rong Jiang; William E Kraus; Svati H Shah; Ilene C Siegler; Elizabeth R Hauser; Redford B Williams Journal: Transl Psychiatry Date: 2020-10-20 Impact factor: 6.222
Authors: Sarah Negash; Nadja Kartschmit; Rafael T Mikolajczyk; Stefan Watzke; Paula Mayara Matos Fialho; Claudia R Pischke; Heide Busse; Stefanie M Helmer; Christiane Stock; Hajo Zeeb; Claus Wendt; Yasemin Niephaus; Andrea Schmidt-Pokrzywniak Journal: Front Psychiatry Date: 2021-12-16 Impact factor: 4.157
Authors: Cecilia Superchi; Florie Brion Bouvier; Chiara Gerardi; Montserrat Carmona; Lorena San Miguel; Luis María Sánchez-Gómez; Iñaki Imaz-Iglesia; Paula Garcia; Jacques Demotes; Rita Banzi; Raphaël Porcher Journal: BMJ Open Date: 2022-05-06 Impact factor: 3.006
Authors: Werner Vach; Antonia Zapf; Amra Hot; Patrick M Bossuyt; Oke Gerke; Simone Wahl Journal: BMC Med Res Methodol Date: 2021-06-01 Impact factor: 4.615